March 13, 2025 - Baltimore, MD 21205, USA
Special form of drug delivery revolutionised disease therapy with accuracy, regulated release and specific effects that can make it even more effective. The two natural carriers with the greatest promise of delivering drugs are hyaluronic acid (HA) and chondroitin sulfate (CS). These molecules are famous for being biocompatible, biodegradable and used to load and deliver therapeutic drugs.
Figure 1. Hyaluronic Acid and Chondroitin Sulfate. (Manjot Kaur, et al.; 2023)
HA and CS were also used in other delivery systems including hydrogels, nanoparticles and liposomes. They are like one another but they are very different in form, action and therapeutic role. In this essay, I will compare hyaluronic acid and chondroitin sulfate drug delivery platforms in totality, to explain what is different, what is better, and what is done with them.
Natural hyaluronic acid is an unnatural polysaccharide, consisting of repeating disaccharide units of glucuronic acid and N-acetylglucosamine. This simple yet versatile structure gives HA properties like high hydrophilicity, biocompatibility, and biodegradability. The tissues are all over the body, particularly in the extracellular matrix (ECM) of connective tissues such as skin, joints and cartilage.
Hyaluronic acid helps deliver drugs by facilitating solubility, stability and controlled release. Because HA is highly hydrophilic, HA-based drug delivery systems tend to be hydrogels or nanoparticles that could encapsulate and release drugs in an extended fashion. HA can also be chemically modified for drug-delivery (eg, crosslinked to create more stable, biocompatible molecules).
A major way in which HA helps to deliver drugs is by binding to receptors on cell surfaces – specifically the CD44 receptor that's ubiquitous on tumor cells and inflammatory cells. This receptor-ligand coupling allows HA to deliver drugs directly into target tissues - tumours or inflamed joints, for example - to increase specificity and minimise the systemic side effects of the drug.
Biocompatibility and biodegradability are among hyaluronic acid's most important drug delivery properties. HA is non-immunogenic and there is a minimal probability of any side effects in the body. It's also biodegradable so it doesn't become locked in tissues or develop chronic toxic effects. The fact that HA also retains so much water makes it an ideal material for hydrogels, which can deliver localised, long-term drug release.
The applications of hyaluronic acid are very numerous, for example in cancer, osteoarthritis and wound care. HA nanoparticles, for example, have been used to deliver chemotherapeutics to tumours using the enhanced permeability and retention (EPR) system to promote drug absorption into the tumour cells. HA hydrogels also were applied to joint spaces to deliver anti-inflammatory drugs that provide local analgesia with less gastrointestinal side effects in osteoarthritis.
By keeping the tissues moist, so cells can migrate and develop, HA hydrogels were also used to heal wounds. All these attributes make HA an evolvable biomaterial in multiple therapeutic areas.
A second glycosaminoglycan is chondroitin sulfate consisting of repeating disaccharide molecules of glucuronic acid and N-acetylgalactosamine sulphate. It's richest in cartilage, bone and cornea and it restores the function and elasticity of the extracellular matrix. Chondroitin sulfate is extremely hydrophilic.
Chondroitin sulfate can seal and release drugs in drug delivery system, just like hyaluronic acid. Since high water retention capacity and ability to form gels, it's a good agent carrier for drug, both in the topical and systemic sense. The release rate is also controlled by chondroitin sulfate adjusting the density and network form of the drug-carrier system.
The chondroitin sulfate can also be applied to nanoparticles or liposomes to deliver the drug where it functions as a stabiliser and transports the drugs to the desired site. It also binds to cell surface receptors, particularly those involved in cartilage repair and regeneration, so it has more effective targeting capabilities.
It is this biocompatibility and tissue-regeneration action that make chondroitin sulfate a winner when it comes to drug delivery. Especially its cartilage healing property, which is the reason why it is so great for osteoarthritis and other degenerative diseases.
And chondroitin sulfate is often used in combination with other molecules, such as hyaluronic acid or collagen. That combination can be applied to optimise drug delivery systems, especially in localised therapy like joint injections or tissue engineering.
It's in osteoarthritis, the commonest disease where we see delivery systems based on chondroitin sulfate, used to regenerate damaged cartilage and reduce inflammation. And CS hydrogels or nanoparticles also used for other joint disorders. So too was chondroitin sulfate as a transporter of gene therapy, particularly for tissue regeneration and wound healing.
This association with cartilage receptors makes chondroitin sulfate an ideal candidate for the administration of therapeutic or regenerative agent into cartilage.
Hyaluronic acid and chondroitin sulfate are structurally the same as glycosaminoglycans, but chemically different. HA from glucuronic acid and N-acetylglucosamine; chondroitin sulfate from glucuronic acid and N-acetylgalactosamine sulfate. Since their difference struture lead to variations in their physics (weight in molecules, water-sequestration capacity) determines their ability to act as drug carriers.
Both HA and CS have targeting because they interact with receptors on the surface of cells. Since HA acts chiefly on the CD44 receptor, which mediates cell adhesion and migration, it is ideal for cancer cells and inflammatory organs. Chondroitin sulfate, however, is more readily available at cartilage receptors, which lends it a better fit for osteoarthritis and cartilage repair.
Release kinetics of drugs encapsulated in HA and CS systems are different because of the difference in the chemistry of the molecules. HA can sustain drug control release (especially in hydrogels) by retains water, while chondroitin sulfate crosslinking density can be varied to control release rate. Both can be designed for drug-controlled release but HA tends to be preferred for longer release while CS is ideal for local delivery with shorter release.
Both HA and CS are biodegradable and biocompatible, so can be safely applied in medicine. HA is abundant in the human body and is rapidly broken down by hyaluronidase, so it is suitable for short-term use. Chondroitin sulfate too breaks down over time, but is slower so it could work better as a sustained-release therapy for tissues repair.
Production of HA and CS is cheap, but HA is more accessible since it is abundant in the human body and is widely used for medicinal purposes. But manufacturing HA-based drug delivery devices is expensive depending on the complexity of the formulation. CS is also cheap, but it might be harder to manufacture in massive amounts as it comes from animal cartilage. These systemre, however, can be synthesised or customized to a particular drug delivery.
Hyaluronic acid and chondroitin sulfate are different in terms of drug delivery mechanisms and therapeutic effects. Hyaluronic acid is best suited to use on tumors and inflammation because it binds to CD44 receptors, and chondroitin sulfate is best suited for use in cartilage repair and tissue regeneration. Which of the two biomolecules to choose hinges on the targeted tissue, dose and drug-release rates, and therapeutic objectives. As we know more and more about the plethora of disease-causing diseases, both hyaluronic acid and chondroitin sulfate are likely to be even more prominent components in future novel drug delivery systems that can provide targeted, long-term and effective therapies.
References
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
